77 research outputs found
Supplemental Material, Supp_Material - Diagnosis, Treatment and Follow Up of Acute Pulmonary Embolism: Consensus Practice from the PERT Consortium
No full textSupplemental Material, Supp_Material for Diagnosis, Treatment and Follow Up of Acute Pulmonary Embolism: Consensus Practice from the PERT Consortium by Belinda Rivera-Lebron, Michael McDaniel, Kamran Ahrar, Abdulah Alrifai, David M. Dudzinski, Christina Fanola, Danielle Blais, David Janicke, Roman Melamed, Kerry Mohrien, Elizabeth Rozycki, Charles B. Ross, Andrew J. Klein, Parth Rali, Nicholas R. Teman, Leoara Yarboro, Eugene Ichinose, Aditya M. Sharma, Jason A. Bartos, Mahir Elder, Brent Keeling, Harold Palevsky, Soophia Naydenov, Parijat Sen, Nancy Amoroso, Josanna M. Rodriguez-Lopez, George A. Davis, Rachel Rosovsky, Kenneth Rosenfield, Christopher Kabrhel, James Horowitz, Jay S. Giri, Victor Tapson, Richard Channick and the PERT Consortium in Clinical and Applied Thrombosis/Hemostasis</p
Steroid use in elderly critically ill COVID-19 patients.
No full textFunding Information: Support statement: This work was supported by the European Commission, APHP and Health Region West (Norway). Funding information for this article has been deposited with the Crossref Funder Registry. Funding Information: Conflict of interest: C. Jung has nothing to disclose. B. Wernly has nothing to disclose. J. Fjølner has nothing to disclose. R.R. Bruno has nothing to disclose. D. Dudzinski has nothing to disclose. A. Artigas reports grants from Grifols and Fisher&Paykel, personal fees for advisory board work from Grifols, Novartis and Lilly Foundation, outside the submitted work. B. Bollen Pinto has nothing to disclose. J.C. Schefold has nothing to disclose. G. Wolff has nothing to disclose. M. Kelm has nothing to disclose. M. Beil has nothing to disclose. S. Sigal has nothing to disclose. P.V. van Heerden has nothing to disclose. W. Szczeklik has nothing to disclose. M. Czuczwar has nothing to disclose. M. Elhadi has nothing to disclose. M. Joannidis has nothing to disclose. S. Oeyen has nothing to disclose. T. Zafeiridis has nothing to disclose. B. Marsh has nothing to disclose. F.H. Andersen has nothing to disclose. R. Moreno has nothing to disclose. M. Cecconi has nothing to disclose. S. Leaver has nothing to disclose. A. Boumendil has nothing to disclose. D.W. De Lange has nothing to disclose. B. Guidet has nothing to disclose. H. Flaatten has nothing to disclose.publishersversionpublishe
Organizational Ethics in Health Care: Principles, Cases, and Practical Solutions, by Philip J. Boyle, Edwin R. DuBose, Stephen J. Ellingson, David E. Guinn, and David B. McCurdy
No full text
Multidisciplinary approach to the management of pulmonary embolism patients: the pulmonary embolism response team (PERT)
No full textChristopher W Root,1 David M Dudzinski,2 Bishoy Zakhary,3 Oren A Friedman,4 Akhilesh K Sista,5 James M Horowitz6 1Icahn School of Medicine at Mount Sinai, New York, NY, USA; 2Division of Cardiology, Department of Internal Medicine, Massachusetts General Hospital, Boston, MA, USA; 3Department of Internal Medicine, Oregon Health & Science University, Portland, OR, USA; 4Department of Surgery, Cedars-Sinai Medical Center, Los Angeles, CA, USA; 5Division of Vascular and Interventional Radiology, Department of Radiology, NYU Langone Health, New York, NY, USA; 6Leon H. Charney Division of Cardiology, Department of Medicine, NYU Langone Health, New York, NY, USA Abstract: Pulmonary embolism (PE) is a potentially fatal disease with a broad range of treatment options that spans multiple specialties. The rapid evolution and expansion of novel therapies to treat PE make it a disease process that is well suited to a multidisciplinary approach. In order to facilitate a rapid, robust response to the diagnosis of PE, some hospitals have established multidisciplinary pulmonary embolism response teams (PERTs). The PERT model is based on existing multidisciplinary teams such as heart teams and rapid response teams. A PERT is composed of clinicians from the range of specialties involved in the treatment of PE, including pulmonology critical care, interventional radiology, cardiology, and cardiothoracic surgery among others. A PERT is a 24/7 consult service that is able to provide expert advice on the initial management of PE patients and convene in real time to develop a consensus treatment plan specifically tailored to the needs of a particular patient and consistent with the capabilities of the institution. In this review, we discuss the rationale for establishing a PERT and its potential benefits. We discuss considerations in forming a PERT and present case studies of several PERTs currently in operation at different institutions. We also discuss potential difficulties in forming a PERT and review evidence that has been generated by some of the PERTs that have been in operation the longest. Keywords: pulmonary embolism, pulmonary embolism response team, thrombosis, thrombolysis, venous thromboembolis
Intraaortic Balloon Support in Myocardial Infarction Complicated by Cardiogenic Shock
No full textThis chapter provides a summary of the landmark study known as Intraaortic Balloon Support in Myocardial Infarction Complicated by Cardiogenic Shock. Compared to optimal medical therapy (OMT) alone, does intraaortic balloon pump (IABP) counterpulsation reduce mortality in patients with acute myocardial infarction (MI) complicated by cardiogenic shock in whom early revascularization in planned? Starting with that question, the chapter describes the basics of the study, including funding, study location, who was studied, how many patients, study design, study intervention, follow-up, endpoints, results, and criticism and limitations. The chapter briefly reviews other relevant studies and information, discusses implications, and concludes with a relevant clinical case.</p
Echocardiographic Guidance for Catheter-Based Removal of Right-Sided Intracardiac Thrombus
No full text
- …
